A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer
Clinical trial NCT04757363 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04757363
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-11
- Primary completion
- 2027-02-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.